Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 2, 2016, Pages

  Dyakova, Mariana ^a   Shantikumar, Saran ^a   Colquitt, Jill L ^b   Drew, Christian M ^a   Sime, Morag ^a   Maciver, Joanna ^a   Wright, Nicola ^c   Clarke, Aileen ^a   Rees, Karen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b EFFECTIVE EVIDENCE LLP   (United Kingdom)

^c Public Health Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; EMBASE; HUMAN; MEDLINE; OPPORTUNISTIC RISK ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMATIC RISK ASSESSMENT; ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; META ANALYSIS; MIDDLE AGED; MORTALITY; PROCEDURES; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; MIDDLE AGED; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84969963046     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010411.pub2     Document Type: Review

References (90)

1. Family Heart Study Group. British Family Heart Study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice 1994;44(379):62-7.
2. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ 1994;308(6924):313-20.
3. Marteau TM, Kinmonth AL, Thompson S, Pyke S. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. The British Journal of General Practice 1996;46(411):577-82.
4. Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, et al. Costs and cost effectiveness of cardiovascular screening and intervention: the British Family Heart Study. BMJ 1996;312(7041):1269-73.
5. Family Heart Study Group. British Family Heart Study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice 1994;44(379):62-7.
6. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ 1994;308(6924):313-20.
7. Marteau TM, Kinmonth AL, Thompson S, Pyke S. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. The British Journal of General Practice 1996;46(411):577-82.
8. Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, et al. Costs and cost effectiveness of cardiovascular screening and intervention: the British Family Heart Study. BMJ 1996;312(7041):1269-73.
9. Family Heart Study Group. British Family Heart Study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice 1994;44(379):62-7.
10. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ 1994;308(6924):313-20.
11. Marteau TM, Kinmonth AL, Thompson S, Pyke S. he psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. The British Journal of General Practice 1996;46(411):577-82.
12. Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, et al. Costs and cost effectiveness of cardiovascular screening and intervention: the British Family Heart Study. BMJ 1996;312(7041):1269-73.
13. Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011;342:d442.
14. Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, McDonough B, et al. Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Preventive Medicine 2008;46(6):537-44.
15. Christensen B, Engberg M, Lauritzen T. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation 2004;11(3):239-43.
16. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice 2002;51(6):546-52.
17. Kanstrup H, Refsgaard J, Engberg M, Lassen JF, Larsen ML, Lauritzen T. Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care 2002;20(4):219-23.
18. Lauritzen T, Jensen MS, Thomsen JL, Christensen B, Engberg M. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health 2008;36(6):650-61.
19. Lauritzen T, Leboeuf-Yde C, Lunde IM, Nielsen KDB. Ebeltoft project: Baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice 1995;45(399):542-7.
20. Rasmussen SR, Thomsen JL, Kilsmark J, Hvenegaard A, Engberg M, Lauritzen T, et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health 2007;35(4):365-72.
21. Mosca L, Mochari H, Liao M, Christian AH, Edelman DJ, Aggarwal B, et al. A novel family-based intervention trial to improve heart health: FIT Heart: results of a randomized controlled trial. Circulation. Cardiovascular Quality and Outcomes 2008;1(2):98-106.
22. Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348:g3617. [DOI: 10.1136/bmj.g3617]
23. Murray DM, Luepker RV, Pirie PL, Grimm RH, Bloom E, Davis MA, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Preventative Medicine 1986;15(6):661-72.
24. Imperial Cancer Research Fund Oxcheck Study Group. Prevalence of risk factors for heart disease in the Oxcheck trial: implications for screening in primary care. BMJ 1991;301(6784):1057-60.
25. Imperial Cancer Research Fund Oxcheck Study Group. The effectiveness of health checks conducted by nurses in primary care: Final results from the Oxcheck study. BMJ 1995;310(6987):1099-104.
26. Langham S, Thorogood M, Normand C, Muir J, Jones L, Fowler G. Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ 1996;312(7041):1265-8.
27. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. Lancet 1986;327(8486):869-72.
28. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. Recruitment and initial findings. European Heart Journal 1980;1(1):73-80.
29. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results. European Heart Journal 1983;4:141-47.
30. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, et al. The multifactor primary prevention trial in Goteborg, Sweden. European Heart Journal 1986;7(4):279-88.
31. Boylan MJ, Renier CM, Knuths JS, Haller IV. Preventing cardiovascular disease in women: an intervention-control randomized study. Minnesota Medicine 2003;86(5):52-6.
32. Tibblin G, Welin L, Larsson B, Ljungberg IL, Svärdsudd K. The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine 1982;10(1):27-32.
33. Grunfeld E, Manca D, Moineddin R, Thorpe KE, Hoch JS, Campbell-Scherer D, et al. Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Family Practice 2013;14:175.
34. Holt TA, Thorogood M, Griffiths F, Munday S, Friede T, Stables D. Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice 2010;60(573):e137-43.
35. Jacobson TA, Gutkin SW, Harper CR. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study. Current Medical Research and Opinion 2006;22(6):1065-73.
36. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. Journal of Chronic Diseases 1986;39(6):453-63.
37. Koelewijn-van Loon MS, Van der Weijden T, Ronda G, Van Steenkiste B, Winkens B, Elwyn G, et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine 2010;50(1-2):35-44.
38. Lannerstad O, Sternby NH, Isacsson SO, Lindgren G, Lindell SE. Effects of a health screening on mortality and causes of death in middle-aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine 1977;5(3):137-40.
39. Shapiro S. Evaluation of two contrasting types of screening programs. Preventive Medicine 1973;2(2):266-77.
40. Bennett AE, Fraser IG. Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology 1972;1(1):55-60.
41. Ogedegbe G, Plange-Rhule J, Gyamfi J, Chaplin W, Ntim M, Apusiga K, et al. A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol. Implementation Science 2014;9:10.
42. Olsen DM, Kane RL, Proctor PH. A controlled trial of multiphasic screening. New England Journal of Medicine 1976;294(17):925-30.
43. The South-East London Study Group. A controlled trial of multiphasic screening in middle-age: results of the South-East London screening study. International Journal of Epidemiology 1977;6(4):357-63.
44. Theobald H, Bygren LO, Carstensen J, Hauffman M, Engfeldt P. Effects of an assessment of needs for medical and social services on long-term mortality: a randomized controlled study. International Journal of Epidemiology 1998;27(2):194-8.
45. Thorner RM, Djordjevic D, Vuckmanovic C, Pesic B, Culafic B, Mark F. A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine 1973;2(2):295-301.
46. Vagholkar S, Zwar N, Jayasinghe UW, Denney-Wilson E, Patel A, Campbell T, et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: A cluster randomized controlled trial. American Heart Journal 2014;167(1):28-35.
47. Voogdt-Pruis HR, Beusmans GH, Gorgels AP, Kester AD, Van Ree JW. Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. British Journal of General Practice 2010;60(570):40-6.
48. Badenbroek IF, Stol DM, Nielen MMJ, Hollander M, Kraaijenhagen RA, De Wit GA, et al. Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Family Practice 2014;15:90.
49. Ijkema R, Van Aerde MA, Van Der Aalst CM, Van Ballegooijen M, Oudkerk M, De Koning HJ. A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment and coronary artery calcium: The ROBINSCA study. European Journal of Preventive Cardiology 2014;May:S21.
50. Marshall T, Caley M, Hemming K, Gill P, Gale N, Jolly K. Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT. BMC Public Health 2012;12:908.
51. Muntendam P, McCall C, Sanz J, Falk E, Fuster V. The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives. American Heart Journal 2010;160(1):49-57.
52. Wan Q, Harris MF, Zwar N, Campbell T, Patel A, Vagholkar S, et al. Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal 2009;157(3):436-41.
53. Bernard SL, Lux L, Lohr KN (RTI International). QQUIPP: Healthcare Delivery Models for Prevention of Cardiovascular Disease (CVD). London: The Health Foundation, 2009.
54. Beswick AD, Brindle P, Fahey T, Ebrahim S. A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement). NICE Clinical Guidelines No. 67S. London: Royal College of General Practitioners, 2008 (available from www.ncbi.nlm.nih.gov/books/NBK55818/).
55. British Heart Foundation. Cardiovascular disease. www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx (accessed 30 August 2012).
56. British Heart Foundation. Our heart disease facts. www.bhf.org.uk/media/news-from-the-bhf/bhf-facts.aspx (accessed 29 March 2012).
57. Chamnan P, Simmons R, Khaw K, Wareham N, Griffin S. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ 2010;340:c1693.
58. Altman DG, Moher D, Schultz KF. Improving the reporting of randomised trials: The CONSORT statement and beyond. Statistics in Medicine 2012;31(25):2985-97.
59. Cooney MT, Dudina A, Winchup P, Capewell S, Menotti A, Jousilahti P, et al. SCORE Investigators. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. European Journal of Cardiovascular Prevention and Rehabilitation 2009;16(5):541-9.
60. Department of Health. National Service Framework for Coronary Heart Disease. London: Stationery Office, 2000.
61. Department of Health. Putting Prevention First. Vascular Checks: Risk Assessment and Management. Impact Assessment. London: Department of Health, 2008.
62. Department of Health. Economic Modelling for Vascular Checks. London: Department of Health, 2008.
63. Department of Health. Cardiovascular Disease Outcomes Strategy. Improving outcomes for people with or at risk of cardiovascular disease 2013. www.gov.uk/government/uploads/system/uploads/attachment_data/file/217118/9387-2900853-CVD-Outcomes_web1.pdf (accessed 22 March 2015).
64. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34.
65. Every contact counts. Every contact counts. Raising health consciousness using brief interventions. www.everycontactcounts.co.uk/ (accessed 3 August 2012).
66. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2013;385(9963):117-71.
67. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
68. Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ 2008;337:a1371.
69. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD009009.pub2]
70. Lawson K, Fenwick E, Pell ACH, Pell J. Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 3921 people. Heart 2010;96(3):208-12.
71. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
72. NHS. Health check. www.nhs.uk/Planners/NHSHealthCheck/Pages/NHSHealthCheck.aspx (accessed 2 September 2012).
73. National Institute for Health and Care Excellence (NICE). The NICE Indicator Menu for the QOF. https://www.nice.org.uk/standards-and-indicators/qofindicators (accessed 29th January 2016).
74. National Patient Safety Agency, NHS. Healthcare Risk Assessment Made Easy. (available from www.nrls.npsa.nhs.uk/resources/?EntryId45=59825). London: NPSA, 2007.
75. O'Flaherty M, Bishop J, Redpath A, McLaughlin T, Murphy D, Chalmers J, et al. Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ 2009;339:b2613.
76. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
77. Commentary by Khaw KT, Marmot M. Rose's Strategy of Preventive Medicine. The Complete Original Text. Oxford: Oxford University Press, 2008.
78. Short R. Putting Vascular Disease Management into Practice. Bath: Medical Management Services, 2009.
79. Tunstall-Pedoe H (editor). MONICA Monograph and Multimedia Sourcebook. World's Largest Study of Heart Disease, Stroke, Risk Factors and Population Trends 1979-2002. Geneva: WHO, 2003.
80. UK National Screening Committee. The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management. Leicester: University of Leicester, 2008.
81. World Health Organization. Integrated Management of Cardiovascular Risk. Report of a WHO meeting, Geneva, 9-12 July 2002. Geneva: WHO, 2002.
82. World Health Organization. Prevention of Cardiovascular Disease. Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: WHO, 2007.
83. World Health Organization. Media centre: cardiovascular diseases (CVDs). www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed 29 March 2012).
84. World Health Organization. Noncommunicable diseases and mental health. www.who.int/nmh/countries/en/index.html (accessed 26 June 2012).
85. World Health Organization. The European Health Report 2012: Charting the Way to Well-being. www.euro.who.int/en/publications/abstracts/european-health-report-2012 (accessed 20 March 2015).
86. World Health Organization. Global Status Report on Noncommunicable Diseases 2014. www.who.int/nmh/publications/ncd-status-report-2014/en/ (accessed 6 April 2015).
87. World Health Organization. World Health Statistics 2014. www.who.int/gho/publications/world_health_statistics/2014/en/ (accessed 6 April 2015).
88. Wood D, Kinmonth A, Davies G, Yarwood J, Thompson S, Pyke S, et al. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308(6924):313-20.
89. Yusuf S, Hawken S, Ôunpuu T, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. The Lancet 2004;364(9438):937-52.
90. Dyakova M, Drew C, Wright N, Clarke A, Rees K. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD010411]